WIN-Partners CoTSE:3183 +0.31%63 EV-to-FCF is 7.44 as of Jul. 09, 2026, which is 3% below its 10-year median of 7.68. GuruFocus rates TSE:3183 with a GF Score™ of 63/100 and a GF Value™ of 円1,522.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 74 Medical Distribution companies, WIN-Partners Co ranks better than 83.78% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, WIN-Partners Co's Enterprise Value is 円20,117 Mil.
WIN-Partners Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円2,704 Mil. Therefore, WIN-Partners Co's EV-to-FCF for today is 7.44.
The historical rank and industry rank for WIN-Partners Co's EV-to-FCF or its related term are showing as below:
TSE:3183'
s EV-to-FCF Range Over the Past 10 Years
Min: -113.31 Med: 7.68 Max: 30.49
Current: 6.99
During the past 13 years, the highest EV-to-FCF of WIN-Partners Co was 30.49. The lowest was -113.31. And the median was 7.68.
TSE:3183's EV-to-FCF is ranked better than 83.78% of 74
companies
in the Medical Distribution industry
Industry Median: 17.125
vs TSE:3183: 6.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
WIN-Partners Co's PE Ratio (TTM) for today is calculated as:
WIN-Partners Co's share price for today is 円1285.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. WIN-Partners Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円76.313.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
WIN-Partners Co EV-to-FCF Related Terms
WIN-Partners Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for WIN-Partners Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, WIN-Partners Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WIN-Partners Co EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where WIN-Partners Co's EV-to-FCF falls into.
WIN-Partners Co's current Enterprise Value is 円20,117 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. WIN-Partners Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円2,704 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WIN-Partners Co (TSE:3183) has a EV-to-FCF of 7.44 as of Jul. 09, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on WIN-Partners Co and its competitors. This is near median its historical median of 7.68. According to the industry distribution chart, WIN-Partners Co ranks #12 out of 74 companies in the Medical Distribution industry, placing it in the top 16.2%.
Is WIN-Partners Co's EV-to-FCF too high?
WIN-Partners Co's current EV-to-FCF of 7.44 is near median its 10-year median of 7.68. The Medical Distribution industry median EV-to-FCF is 17.13. WIN-Partners Co's value of 7.44 is 56.6% below this industry median. Based on the distribution chart, WIN-Partners Co ranks #12 out of 74 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, WIN-Partners Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, WIN-Partners Co ranks #12 out of 74 companies for EV-to-FCF. This places WIN-Partners Co in the top 16% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 17.13. WIN-Partners Co's value of 7.44 is 56.6% below this benchmark. While the company's 10-year median is 7.68 vs. the industry median of 17.13, WIN-Partners Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.13, based on 74 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WIN-Partners Co's current EV-to-FCF of 7.44 is 56.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on WIN-Partners Co and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WIN-Partners Co's current EV-to-FCF is 7.44, which is near median its own 10-year median of 7.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,522.55, compared to a current price of 円1,285.00 — trading 15.6% below its estimated fair value. The current EV-to-FCF is 7.44, which is near median its 10-year median of 7.68 and 56.6% below the Medical Distribution industry median of 17.13. WIN-Partners Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current EV-to-FCF is 7.44 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WIN-Partners Co (TSE:3183) Overvalued in 2026?
Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued.
The current stock price of 円1,285.00 is trading 15.6% below its estimated GF Value™ of 円1,522.55.
GuruFocus considers WIN-Partners Co to be Modestly Undervalued.
Key valuation signals for TSE:3183:
EV-to-FCF: 7.44 (near median its 10-year median of 7.68)
GF Value™: 円1,522.55 vs. price of 円1,285.00 (15.6% below fair value)
Industry Position: 56.6% below the Medical Distribution median (#12 of 74)
No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
63GF Score
Get the complete analysis for TSE:3183
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3183 has been successfully added to your 
